Sick Money Sick Money argues that the way medicines are developed and paid for is no longer working. Unless we take action we risk a dramatic decline in the pace of drug development and a future in which medicines are only available to the highest bidder. Billy Kenber offers a diagnosis of an industry in crisis and a prescription for how we can fight back.
